I-027

Interference Mix 5

100 μg/mL in methanol (each analyte), Cerilliant^®

• 동의어(들): Qualitative Interference Mixture
• UNSPSC 코드: 41116107
• NACRES: NA.24

속성

• Grade: analytical standard
• Quality Level: 100
• 양식: liquid
• 구성: Carbamazepine, 100 μg/mL ; Levetiracetam, 100 μg/mL ; Metformin hydrochloride, 100 μg/mL (as free base); Phenobarbital, 100 μg/mL ; R(-)-Phenylephrine hydrochloride, 100 μg/mL (as free base); Phenytoin, 100 μg/mL ; Sertraline hydrochloride, 100 μg/mL (as free base); Topiramate, 100 μg/mL ; Zolpidem tartrate, 100 μg/mL ; Zonisamide, 100 μg/mL
• 포장: ampule of 1 mL
• 제조업체/상표: Cerilliant^®
• drug control: psicótropo (Spain); Decreto Lei 15/93: Tabela IV (Portugal)
• 농도: 100 μg/mL in methanol (each analyte)
• 기술: gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• 응용 분야: forensics and toxicology
• 형식: single component solution
• 저장 온도: −20°C

설명

일반 설명

A multi-component solution standard of routinely monitored over-the-counter (OTC) and prescription drugs carbamazepine, metformin, sertraline, zonisamide, levetiracetam, phenobarbital, topiramate, phenytoin, zolpidem and (R)-phenylephrine. This standard is for qualitative use only in the evaluation of interferences between the mix components and target analytes of interest in a testing laboratory′s analytical methods.

법적 정보

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

안전성 정보

• 픽토그램: GHS02,GHS06,GHS08,GHS09
• 신호어: Danger
• 유해 및 위험 성명서: H225,H301 + H311 + H331,H370,H411
• 예방조치 성명서: P210 - P273 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311
• Hazard Classifications: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Aquatic Chronic 2 - Flam. Liq. 2 - STOT SE 1
• 표적 기관: Eyes,Central nervous system
• Storage Class Code: 3 - Flammable liquids
• WGK: WGK 3
• Flash Point (°F): 49.5 °F - closed cup
• Flash Point (°C): 9.7 °C - closed cup